Manuel Ibarra

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Endothelium-Independent Vasodilator Effects of the Flavonoid Quercetin and Its Methylated Metabolites in Rat Conductance and Resistance Arteries

Francisco Pérez‐Vizcaíno, Manuel Ibarra, Ángel Cogolludo et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 190 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

Marius M. Hoeper, Hikmet Al‐Hiti, Raymond L. Benza et al. · The Lancet Respiratory Medicine · 2021 · 161 citations

Medicine, Pharmacology, Pharmacotherapy +9

Nitric Oxide (NO) Scavenging and NO Protecting Effects of Quercetin and Their Biological Significance in Vascular Smooth Muscle

Gustavo López‐López, Laura Moreno, Ángel Cogolludo et al. · Molecular Pharmacology · 2004 · 96 citations

Medicine, Biochemistry, Pharmacology +13

Sex related differences on valproic acid pharmacokinetics after oral single dose

Manuel Ibarra, Marta Vázquez, Pietro Fagiolino et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2013 · 70 citations

Pharmacy, Pharmacokinetics, Pharmacology +14